Teva CEO says not too late to launch Humira biosimilar in 2024
By Steven Scheer JERUSALEM (Reuters) -Teva Pharmaceutical Industries will still pursue launching a biosimilar of AbbVie's blockbuster arthritis drug Humira ...
Source: saltwire.com
Page 2 - Cigna Group Express Scripts News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cigna Group Express Scripts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cigna Group Express Scripts Today - Breaking & Trending Today
Launch of arthritis drug biosimilars ramps up US pressure on pricing 'middlemen'
Seven drugmakers this month launched their own versions known as biosimilars
Source: dunyanews.tv
Analysis-Launch of arthritis drug biosimilars ramps up US pressure on pricing 'middlemen'
Cheaper versions of one of the most costly and widely used arthritis treatments in the U.S. are likely to fuel further scrutiny of the middlemen that negotiate drug prices for most insured...
Source: marketscreener.com
Humira Biosimilars: Five Things to Know
The launch of eight adalimumab biosimilars so far this year ended Humira's 20-year monopoly, but it's not clear yet if these discounted drugs will save patients money.
Source: medscape.com
Health News Roundup: Hunger haunts Ethiopia's Tigray region after years of war; EU investigates Ozempic, weight-loss drug Saxenda after suicidal thoughts reported and more
Read more about Health News Roundup: Hunger haunts Ethiopia's Tigray region after years of war; EU investigates Ozempic, weight-loss drug Saxenda after suicidal thoughts reported and more on Devdiscourse
Source: devdiscourse.com